PVCT Insider Webster Bailey Buys 48,917 Shares

Webster Bailey recently bought 48,917 shares of PVCT on June 30, 2026. The shares were acquired in a transaction not planned under a Rule 10b5-1 trading plan. On Wednesday, shares of PVCT traded near $0.07.

Other Institutional Activity in PVCT

Several institutional investors have shown interest in PVCT. Atlas Wealth LLC opened a new position with 19,620 shares valued at about $999. Meanwhile, other funds like Home Federal Bank of Tennessee and Wealth Preservation Advisors, LLC maintained their positions, holding 100,000 shares valued at $5,100 and 52,600 shares valued at $2,677, respectively.

Insider Buying and Selling at Provectus Biopharmaceuticals, Inc.

In addition to Webster Bailey, other insiders have also been active in acquiring PVCT shares. On June 30, 2026, Lacey John III and Dominic Rodrigues, President of PVCT, each purchased 48,917 and 45,860 shares, respectively. Earlier in the month, on June 5, CEO Edward Pershing bought 9,436 shares and also sold the same amount on the same day. Additionally, on May 28, Pershing acquired another 5,242 shares.

Bottom Line

Webster Bailey's purchase of PVCT shares is part of a broader trend of insider buying at the company. Investors often track such activity for potential insights into the company's prospects. However, it's important to remember that insider transactions are just one piece of the puzzle. As always, these filings reflect past actions and may not indicate current holdings or future intentions.